Table 2.

Treatment Responses and Clinical Outcomes in 2 Treatment Groups

Treatment responses	PIP/TZO (n=59)	Ceftaz/Amikacin (n=59)	p-value
Early response to initial antibiotics	48 (81.4%)	40 (67.8%)	0.091
Complete response to initial antibiotics	41 (69.5%)	33 (55.9%)	0.128
Duration of fever (days)*	2 (1-4)	2 (1-4)	0.426
Duration of antibiotics (days)*	7 (7-10)	9 (7-12)	0.125
Duration of neutropenia (days)*	7 (5-9)	7 (5-11)	0.351
Treatment modification	18 (30.5%)	26 (44.1%)	0.128

*Data are median (interquartile range)